Research Article
Cryptococcosis in Patients following Kidney Transplantation: A 9-Year Retrospective Clinical Analysis at a Chinese Tertiary Hospital
Table 2
Six-month outcome of cryptococcosis with different initial antifungal therapies.
| Initial therapy | Total | CM or disseminated cryptococcosis | Lung disease only | Total | Evaluated | Death | Mortality (%) | Evaluated | Death | Mortality (%) | Evaluated | Death | Mortality |
| Liposomal-AMB + 5-FC | 7 | 7 | 2 | 28.6 | 7 | 2 | 28.6 | 0 | 0 | 0 | FLZ ± 5-FC | 22 | 22 | 3 | 13.6 | 17 | 3 | 17.6 | 5 | 0 | 0 | FLZ 400 mg daily ± 5-FC | 18 | 18 | 3 | 16.7 | 14 | 3 | 21.3 | 4 | 0 | 0 | FLZ 800 mg daily ± 5-FC | 4 | 4 | 0 | 0 | 3 | 0 | 0 | 1 | 0 | 0 | VRZ ± 5-FC | 7 | 7 | 0 | 0 | 5 | 0 | 0 | 2 | 0 | 0 | Itraconazole | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
|
|